Dextromethorphan and Pyrilamine and Ibritumomab Intravenous
Determining the interaction of Dextromethorphan and Pyrilamine and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextromethorphan / pyrilamine
Brand name: Capron DM
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextromethorphan and Pyrilamine-Ibritumomab Tiuxetan
- Dextromethorphan and Pyrilamine-Ibrutinib
- Dextromethorphan and Pyrilamine-Ibrutinib Capsules
- Dextromethorphan and Pyrilamine-Ibrutinib Tablets
- Dextromethorphan and Pyrilamine-Ibu
- Dextromethorphan and Pyrilamine-IBU Tablets
- Ibritumomab Intravenous-Dextromethorphan and quinidine
- Ibritumomab Intravenous-Dextromethorphan Capsules
- Ibritumomab Intravenous-Dextromethorphan Chewable Tablets
- Ibritumomab Intravenous-Dextromethorphan Extended-Release Suspension
- Ibritumomab Intravenous-Dextromethorphan Hydrobromide
- Ibritumomab Intravenous-Dextromethorphan Hydrobromide and Quinidine Sulfate